Cargando…
Comparison of levetiracetam with phenytoin for the prevention of intravenous busulfan-induced seizures in hematopoietic cell transplantation recipients
PURPOSE: Busulfan is used as a conditioning regimen for hematopoietic stem cell transplantation and is known to cause seizures as a side effect. As various anticonvulsant drugs have been reported, we conducted a retrospective investigation regarding the preventive effects and adverse events associat...
Autores principales: | Akiyama, Kana, Kume, Tetsuo, Fukaya, Masafumi, Shiki, Ikue, Enami, Terukazu, Tatara, Raine, Shino, Michihiro, Ikeda, Takashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132870/ https://www.ncbi.nlm.nih.gov/pubmed/30083882 http://dx.doi.org/10.1007/s00280-018-3659-8 |
Ejemplares similares
-
Benefit of Reducing Body Weight Loss with A Nutritional Support Pathway in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
por: Aoyama, Takashi, et al.
Publicado: (2019) -
Phenytoin as seizure prophylaxis in hematopoietic stem cell transplantation with busulfan conditioning
por: Germeraad, R. S., et al.
Publicado: (2022) -
A Comparison of Seizure Prophylaxis: Phenytoin Versus Levetiracetam
por: Fiani, Brian, et al.
Publicado: (2021) -
Response-adapted treatment with upfront high-dose chemotherapy followed by autologous stem-cell transplantation rescue or consolidation phase high-dose methotrexate for primary central nervous system lymphoma: a long-term mono-center study
por: Nakasu, Yoko, et al.
Publicado: (2016) -
Comparison of Efficacy and Safety of Levetiracetam Versus Phenytoin for Post-craniotomy Seizure Prophylaxis
por: Faghihjouibari, Morteza, et al.
Publicado: (2023)